Mid-Atlantic Claims $8.5 Billion Slice of $62 Billion North American Life Science Capital/MRO Investment Pie
Mid-Atlantic Claims $8.5 Billion Slice of $62 Billion North American Life Science Capital/MRO Investment Pie
Attachment: Pharma-Biotech Mid-Atlantic Starts, Oct 2014
SUGAR LAND--October 31, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--There are more than 1,400 active reported Pharmaceutical-Biotech capital and maintenance (MRO) projects in North America, representing a total investment value (TIV) of nearly $62 billion. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry database, the Mid-Atlantic region is at the top of that investment, accounting for an $8.5 billion portion of that spending divided over 176 projects.
Within this article: Details on the industry's outlook and key projects, including those from major companies such as United Therapeutics Corporation (NASDAQ:UTHR).
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- It's a Wrap! Pharma-Bio Industry Set to Complete $2 Billion-Plus in North A...
- Pharma-Bio Industry to Inject $2 Billion Investment for Capital & Maintenan...
- Big-Ticket Items Lead North Carolina to $18.7 Billion in Projects Under Con...
- ISM: U.S. Manufacturing Activity Contracts Again But Shows Improvement
- Florida Sees $7.2 Billion in Industrial Projects Under Construction